Chatchanok Udomtanakunchai

Chatchanok Udomtanakunchai


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SDSilvia Dei
Silvia Dei
LBLaura Braconi
Laura Braconi
ATAlfonso Trezza
Alfonso Trezza
MMMarta Menicatti
Marta Menicatti
Marialessandra ContinoMarialessandra Contino
Marialessandra Contino
ETElisabetta Teodori
Elisabetta Teodori

11 August 2011 in Dose-Response
Verified
Journal Article
Open access
KRKanokporn Noy Rithidech
Kanokporn Noy Rithidech
CUChatchanok Udomtanakunchai
Chatchanok Udomtanakunchai
LHLouise M. Honikel
Louise M. Honikel
EWElbert B. Whorton
Elbert B. Whorton
In spite of extensive research, assessment of potential health risks associated with exposure to low-dose (≤ 0.1 Gy) radiation is still challenging. We evaluated the in vivo induction of genomic instability, expressed as late-occurring chromosome aberrations, in bone-marrow cells of two strains of mouse with different genetic background, i.e. the radiosensitive BALB/cJ and the radioresistant C57BL/6J strains following a whole-body exposure to varying doses of 137Cs gamma rays (0, 0.05, 0.1, and 1.0 Gy). A total of five mice per dose per strain were sacrificed at various times post-irradiation up to 6 months for sample collections. Three-color fluorescence in situ hybridization for mouse chromosomes 1, 2, and 3 was used for the analysis of stable-aberrations in metaphase-cells. All other visible gross structural-abnormalities involving non-painted-chromosomes were also evaluated on the same metaphase-cells used for scoring the stable-aberrations of painted-chromosomes. Our new data demonstrated in bone-marrow cells from both strains that low doses of low LET-radiation (as low as 0.05 Gy) are incapable of inducing genomic instability but are capable of reducing specific aberration-types below the spontaneous rate with time post-irradiation. However, the results showed the induction of genomic instability by 1.0 Gy of 137Cs gamma rays in the radiosensitive strain only.

18 June 2021 in Life
Verified
Journal Article
Open access
PDF file
Khin Thandar HtunKhin Thandar Htun
Khin Thandar Htun
JPJie Pan
Jie Pan
DPDuanghathai Pasanta
Duanghathai Pasanta
MTMontree Tungjai
Montree Tungjai
CUChatchanok Udomtanakunchai
Chatchanok Udomtanakunchai
Suchart KothanSuchart Kothan
Suchart Kothan
(1) Since the obesity prevalence rate has been consistently increasing, it is necessary to find an effective way to prevent and treat it. Although progress is being made to reduce obesity in the young adult population, a better understanding of obesity-related metabolomics and related biochemical mechanisms is urgently needed for developing appropriate screening strategies. Therefore, the aim of this study is to identify the serum metabolic profile associated with young adult obesity and its metabolic phenotypes. (2) Methods: The serum metabolic profile of 30 obese and 30 normal-weight young adults was obtained using proton nuclear magnetic resonance spectroscopy (1H NMR). 1H NMR spectra were integrated into 24 integration regions, which reflect relative metabolites, and were used as statistical variables. (3) Results: The obese group showed increased levels of lipids, glucose, glutamate, N-acetyl glycoprotein, alanine, lactate, 3 hydroxybutyrate and branch chain amino acid (BCAA), and decreased levels of choline as compared with the normal-weight group. Non-hyperlipidemia obese adults showed lower levels of lipids and lactate, glutamate, acetoacetate, N-acetyl glycoprotein, isoleucine, and higher levels of choline and glutamine, as compared with hyperlipidemic obese adults. (4) Conclusions: This study reveals valuable findings in the field of metabolomics and young adult obesity. We propose several serum biomarkers that distinguish between normal weight and obese adults, i.e., glutamine (higher in the normal group, p < 0.05), and lactate, BCAAs, acetoacetate and 3-hydroxybutyrate (higher in the obese group, p < 0.05). In addition, visceral fat and serum TG, glutamate, acetoacetate, N-acetyl glycoprotein, unsaturated lipid, isoleucine, and VLDL/LDL are higher (p < 0.05) in the obese with hyperlipidemia. Therefore, they can be used as biomarkers to identify these two types of obesity.

28 March 2019 in Cell Biochemistry and Biophysics
Verified
Journal Article
Closed access
PDF file
BSBenjamaporn Supawat
Benjamaporn Supawat
CUChatchanok Udomtanakunchai
Chatchanok Udomtanakunchai
Suchart KothanSuchart Kothan
Suchart Kothan
MTMontree Tungjai
Montree Tungjai

KRKanokporn Rithidech
Kanokporn Rithidech
CUChatchanok Udomtanakunchai
Chatchanok Udomtanakunchai
LHLouise Honikel
Louise Honikel
EWElbert Whorton
Elbert Whorton
It is clear that high-dose radiation is harmful. However, despite extensive research, assessment of potential health-risks associated with exposure to low-dose radiation (at doses below or equal to 0.1 Gy) is still challenging. Recently, we reported that 0.05 Gy of 137Cs gamma rays (the existing limit for radiation-exposure in the workplace) was incapable of inducing significant in vivo genomic instability (measured by the presence of late-occurring chromosomal damage at 6 months post-irradiation) in bone marrow (BM) cells of two mouse strains, one with constitutively high and one with intermediate levels of the repair enzyme DNA-dependent protein-kinase catalytic-subunit (DNA-PKcs). In this study, we present evidence for a lack of genomic instability in BM cells of the severely combined-immunodeficiency (SCID/J) mouse (which has an extremely low-level of DNA-PKcs activity) exposed whole-body to low-dose radiation (0.05 Gy). Together with our previous report, the data indicate that low-dose radiation (0.05 Gy) is incapable of inducing genomic instability in vivo (regardless of the levels of DNA-PKcs activity of the exposed mice), yet higher doses of radiation (0.1 and 1 Gy) do induce genomic instability in mice with intermediate and extremely low-levels of DNA-PKcs activity (indicating an important role of DNA-PKcs in DNA repair).

1 March 2018 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SDSilvia Dei
Silvia Dei
MCMarcella Coronnello
Marcella Coronnello
GBGianluca Bartolucci
Gianluca Bartolucci
DMDina Manetti
Dina Manetti
MRMaria Novella Romanelli
Maria Novella Romanelli
ETElisabetta Teodori
Elisabetta Teodori